Orlando, FL -- (SBWIRE) -- 10/29/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), PDL BioPharma Inc. (NASDAQ:PDLI).
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) shares dropped 2.80% to $2.43. Wolf Haldenstein Adler Freeman & Herz LLP on Oct. 24 announces that a class action lawsuit has been filed in the United States District Court, District of Connecticut, on behalf of all persons who purchased or otherwise acquired common stock of Achillion Pharmaceuticals, Inc. ("Achillion" or the "Company") (NASDAQ GS:ACHN) between August 8, 2012 and September 30, 2013, inclusive (the "Class Period"), against the Company and certain of the Company's officers ("Defendants"), alleging securities fraud pursuant to Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [15 U.S.C. §§ 78j(b) and 78t(a)] and Rule 10b-5 promulgated thereunder by the SEC [17 C.F.R. § 240.10b-5].
Are investors worried about the recent updates with ACHN? Find out with a free trend analysis HERE
PDL BioPharma Inc. (NASDAQ:PDLI) shares decreased 0.24% to $8.39 in the last trading session. The company on Oct. 21 said it is buying the rights to receive royalty and milestone payments on several Type 2 diabetes treatments from Depomed in a deal valued at $240.5 million. The biggest earner in the group is Glumetza, which is marketed by Santarus Inc. PDL said Depomed received $42.8 million in royalty payments on that drug in 2012.
Additionally, the company announced that the Company will release its third quarter 2013 financial results for the period ended September 30, 2013, on Wednesday, November 6, 2013, after market close. PDL's management will host a conference call and webcast that day at 4:30 p.m. Eastern Time to discuss the financial results.
Is PDLI going to continue its rally or drop like a rock? Find out with a free trend analysis HERE
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)